Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome

Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials